StockData
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Inc. (DMAC) stock

DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$8.59+0.21 (+2.51%)

Close on Nov 18, 2026Market cap $463.22MP/E –Yield –

DiaMedica Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

DiaMedica Therapeutics's revenue for the twelve months ending Dec 31, 2018 was $500.00K. For fiscal 2018 it was $500.00K.

Annual revenue

PeriodPeriod endValueChange
FY2018Dec 31, 2018$500.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2018Dec 31, 2018$0–
Q3 FY2018Sep 30, 2018$500.00K–

More DiaMedica Therapeutics figures

See a number that looks wrong?